Autoimmune liver diseases, including autoimmune hepatitis, primary biliary cholangitis, and primary sclerosing cholangitis, are the fourth most common cause of transplantation worldwide. Although immunosuppressive therapies can induce remission or slow disease progression, transplantation remains the definitive treatment for patients with end-stage liver disease, intractable symptoms, or acute liver failure. This chapter provides a comprehensive overview of pre- and post-transplant evaluation processes in patients with autoimmune liver diseases.
Keywords: Autoimmune liver disease, chronic rejection, liver transplantation, immunosupression